QR Code

Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant <i>Staphylococcus aureus</i> Infective Endocarditis

<b>Background.</b> Recurrent therapeutic failures reported for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infective endocarditis (IE) with vancomycin may be due to poor bactericidal activity. Alternative antibacterial approaches using bacteriophages may overcome this...

Description complète

Enregistré dans:
Auteurs principaux: Jonathan Save, Yok-Ai Que, José Entenza, Grégory Resch
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2022-08-01
Collection:Viruses
Sujets:
bacteriophage
phage therapy
infective endocarditis
MRSA
vancomycin
Accès en ligne:https://www.mdpi.com/1999-4915/14/8/1792
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires